Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
In the transition from normal glucose tolerance (NGT) to type 2 diabetes mellitus (T2DM), the role of β-cell dysfunction and peripheral insulin resistance (IR) is well established. However, the impact of dysfunctional adipose tissue has not been fully elucidated. The aim of this study was to evaluate the role of resistance to the antilipolytic effect of insulin (adipose tissue IR [Adipo-IR]) in a large group of subjects with NGT, impaired glucose tolerance (IGT), and T2DM. Three hundred two subjects with varying glucose tolerance received an oral glucose tolerance test (OGTT) and euglycemic insulin clamp. We evaluated Adipo-IR (fasting and mean OGTT plasma free fatty acid [FFA] × insulin concentrations), peripheral IR (1/[Matsuda index] and (M/I)−1 value), and β-cell function (calculated as the ratio of the increment in plasma insulin to glucose [OGTT/IR (ΔI/ΔG ÷ IR)]). Fasting Adipo-IR was increased twofold in obese subjects with NGT and IGT versus lean subjects with NGT (8.0 ± 1.1 and 9.2 ± 0.7 vs. 4.1 ± 0.3, respectively) and threefold in subjects with T2DM (11.9 ± 0.6; P < 0.001). Progressive decline in ΔI/ΔG ÷ IR was associated with a progressive impairment in FFA suppression during OGTT, whereas the rise in mean plasma glucose concentration only became manifest when subjects became overtly diabetic. The progressive decline in β-cell function that begins in individuals with NGT is associated with a progressive increase in FFA and fasting Adipo-IR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in the presence of Adipo-IR, FFA release is not suppressed despite high insulin concentrations.45”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [45]
Citations
Cites
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“Data Analysis Insulin sensitivity was assessed by Matsuda index (32) from the plasma glucose and insulin concentrations measured during the OGTT.”
MethodSelf-citationAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Self-citationPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743 · cited 1×
“Thus, with progression from lean NGT to obese NGT to IGT, the insulin secretion/insulin resistance (disposition) index declined and was closely related to the deterioration in OGTT, consistent with previous studies from our group and others (31,34,39,40).”
ResultMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“, the impaired suppression of lipolysis in the presence of high insulin levels, has been associated with glucose intolerance, and elevated plasma FFA have been shown to impair muscle insulin signaling, promote hepatic gluconeogenesis, and impair glucose-stimulated insulin response (7-13).”
BackgroundScherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050 · cited 1×
“, the impaired suppression of lipolysis in the presence of high insulin levels, has been associated with glucose intolerance, and elevated plasma FFA have been shown to impair muscle insulin signaling, promote hepatic gluconeogenesis, and impair glucose-stimulated insulin response (7-13).”
BackgroundSelf-citationFatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 1×
“In contrast to the OGTT, studies with the stepped hyperinsulinemic clamp consistently have demonstrated impaired suppression of plasma FFA and glycerol concentrations and (14)C-palmitate turnover (18,22,24) (i.”
ResultBoden, G. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.007 · Cited by 853 · cited 1×
“Insulin acts on adipose tissue 1) by stimulating glucose uptake and triglyceride synthesis and 2) by suppressing triglyceride hydrolysis and release of FFA and glycerol into the circulation (6,7).”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 4×
“In contrast to the OGTT, studies with the stepped hyperinsulinemic clamp consistently have demonstrated impaired suppression of plasma FFA and glycerol concentrations and (14)C-palmitate turnover (18,22,24) (i.”
BackgroundMethodResultInfluentialSelf-citation
Cited by
Items 301–346 of 346
Burbano, J., & Sanchez, L. D. (2020) · doi:10.11565/arsmed.v45i1.1600
Драг, Я., Knapik-Czajka, M. E., Gawędzka, A., Гдула-Аргасинска, И., & Яцкевич, Е. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521050018
McIver, V. J. (2026) · e-space (Manchester Metropolitan University) · doi:10.83056/mmu.32477979
Чернышов, В. А., Nesen, А. О., & Babenko, O. V. (2021) · Ukrainian Therapeutical Journal · doi:10.30978/utj2021-3-11
Walker, M., Yu, X., & Gastaldelli, A. (2022) · doi:10.1093/med/9780198870197.003.0248
Self-citationImpact of gut-derived metabollites on substrate metabolism and metabolic health
Gonzalez Hernandez Manuel, A. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201027mgh
Şentürk, M. (2022) · Biochemistry · doi:10.5772/intechopen.100950 · Cited by 1
Sasaki, N., Maeda, R., Ozono, R., Yoshimura, K., Nakano, Y., & Higashi, Y. (2022) · doi:10.2337/figshare.20348934
Toward a Cell Culture Model of Portal Axis Lipid HandlingPreprint
Cook, J. R., Green, P. H. R., & Haeusler, R. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.30.518512
“Introduction Metabolic dysfunction in white adipose tissue (WAT) is thought to be an early event in the natural history of insulin resistance (IR) [1], and mesenteric (visceral) WAT seems to be particularly susceptible [2].”
BackgroundHyperinsulenemia, Obesity, and T2 Diabetes: A continuum
Chawla, R. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01193-5
Review article: Type 2 diabetes mellitus: Pathogenesis and therapeutic intervention
Albajy, M. A., Mihailescu, D. F., Nawfal, A. S., & Mohammed, J. A. (2023) · AIP conference proceedings · doi:10.1063/5.0112591
Harmsen, J. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231213jh
Syndromes of severe insulin resistance: lessons from nature
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00005-x
İnsülin 100 Yıllık Mucize Hormon
Cerit, E. T., Barlas, T., Atalar, K., Bahçelioğlu, M., Kaplanoğlu, G. T., Seymen, C. M., Erdem, H. B., Ergün, M. A., Demir, Ö., Gülbahar, Ö., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.871
Lin, Y., Liu, Z., Li, Z., Li, J., Bao, X., Xia, Y., & Zhang, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4157511/v1
Can First Trimester Plasma Protein A Level Predict Gestational Diabetes Mellitus
Yıldırım, S. B., Altuntaş, N. B., Muhtaroğlu, A., & Albayrak, M. (2025) · Medical Records · doi:10.37990/medr.1598384
Adipose Tissue Insulin Sensitivity, Adipocyte Function, and Regulation of Systemic Metabolism
Hosooka, T. (2025) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.78.131
Das, S. (2025) · Research Square · doi:10.21203/rs.3.rs-7297145/v1 · Cited by 1
Involvement of Activin E depletion in metabolic dysfunction-associated steatohepatitis
Sakaki, M., Shikata, T., Aoki, K., 高野, 政., Kamatari, Y., Kurisaki, A., Funaba, M., & Hashimoto, O. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102339
“As glucose tolerance decreases, as observed in diabetes, Adipo-IR values worsen, reflecting increased insulin resistance in adipose tissue [22].”
Briggs, O. N., Abiola, S. A., & Elechi-Amadi, K. N. (2025) · Asian Journal of Research in Biochemistry · doi:10.9734/ajrb/2025/v15i6450
Oktarina, N. H., Kurniawan, L. B., Nurahmi, N., Patellongi, I. J., HUSAINI, H., & Widaningsih, Y. (2025) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.24.05761-9
Zeng, K., Chen, B., Li, H., Ren, N., Song, Y., Liang, M., Yin, Y., Huang, Y.-L., Liu, T., Lin, Y., et al. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100436
“Conventional management strategies for T2DM predominantly involve pharmacological interventions aimed at glycemic control, including metformin, insulin, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and sodium-glucose cotransporter 2 (SGLT-2) inhibitors [6,7].”
Antonio-Villa, N. E., Juárez-Rojas, J. G., Posadas‐Sánchez, R., Reyes-Barrera, J., & Medina-Urrutia, A. X. (2024) · Figshare · doi:10.6084/m9.figshare.26580206
Liu, X., Abudukeremu, A., Jiang, Y., Cao, Z., Wu, M., Ma, J., Sun, R., He, W., Chen, Z., Chen, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590398
Foss-freitas, M. C., Akıncı, B., Neidert, A., Bartlett, V. J., Hurh, E., Karwatowska‐Prokopczuk, E., & Oral, E. A. (2021) · Figshare · doi:10.6084/m9.figshare.17127352
Antonio-Villa, N. E., Juárez-Rojas, J. G., Posadas‐Sánchez, R., Reyes-Barrera, J., & Medina-Urrutia, A. X. (2024) · Figshare · doi:10.6084/m9.figshare.26580209
Pathogenesis of type 2 diabetes
Honka, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00376-9
Prado, N. A., & Brown, J. L. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-87707-0_15
Heng, T. A. N. G., Zhifeng, C. H. E. N., Shenfu, W. A. N. G., Li, W., & ZHANG, W. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02233-x
“Static IR measures may not fully capture dynamic glucoregulatory changes, including progressive βcell dysfunction [27].”
LUMULA, F., Kurniawan, L. B., Nurahmi, N., SANUSI, H. D., Esa, T., & ZAINUDDIN, A. A. (2026) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.25.05986-8
Stage-specific utility of obesity indices across the chronic kidney disease continuum
Zhu, Z., Ren, K., Duan, X., Hu, X., Lv, Y., Wang, D., Jin, H., Zhang, L., & Wang, Y. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2646000
Marziou, A. (2021) · theses.fr (ABES) · doi:10.70675/5ac5d7aez174dz4164z86fbze535a2a8522a
Recazens, E. (2021) · theses.fr (ABES) · doi:10.70675/5b66fe82zcbbbz4251z98c0z2bb967f598c2
Kutoh, E., & Kuto, A. N. (2026) · medRxiv · doi:10.64898/2026.05.31.26354545
Arner, P., Sørensen, T. I. A., & Andersson, D. P. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106299
“48 We presently found that insulin resistance overrides enlarged fat cells as risk factor for future IGM.”
Mitrovic, M., Horakova, O., Riecan, M., Kleinová, V., Zouhar, P., Cajka, T., Kuda, O., Rossmeislova, L., & Rossmeisl, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.08.730805
Liu, T., Tang, Z., Aierken, Z., Zhang, J., & Lei, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1805548
“Excessive free fatty acids in obese patients contribute to the onset and progression of insulin resistance (36, 37).”
Yamaguchi, F., Kiyonaga, T., Nitta, S., Yoshinaga, N., Akieda‐Asai, S., Date, Y., & Sawada, H. (2026) · Journal of Public Health Research · doi:10.1177/22799036261471211
“7,8 However, the relationship between body mass index (BMI) and diabetes risk is not identical across populations.”
Camara, L. R. P., & Vilas‐Boas, E. A. (2026) · Frontiers in Network Physiology · doi:10.3389/fnetp.2026.1864821
“Obesity is associated with elevated circulating fatty acids (Abdul-Ghani et al., 2008; Hershkop et al., 2016; Gastaldelli et al., 2017) and white adipose tissue remodeling, characterized by adipocyte hypertrophy and increased release of free fatty acids (FFAs) and pro-inflammatory cytokines, which…”
Molecular signaling networks that connect tissue dysfunction to systemic insulin resistance
Mir, R., Algehainy, N. A., Jalal, M. M., Altayar, M. A., Almotairi, R., Tayeb, F. J., Bedaiwi, R. I., Altemani, F. H., Almasoudi, K. S., Albalawi, I. A., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1952238
KAHL, S., LaMoia, T. E., Jonuscheit, M., Heilmann, G., Rohrer, S., Bobrov, P., Dewidar, B., Pafili, K., Sarabhai, T., Schrauwen‐Hinderling, V. B., et al. (2026) · Drugs · doi:10.1007/s40265-026-02370-6
Sasaki, N., Ueno, Y., Ozono, R., Nakano, Y., & Higashi, Y. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004466
Metadata
- Authors
- Gastaldelli, A., Gaggini, M., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Istituto di Fisiologia Clinica (IT)
- Corresponding author
- Gastaldelli, Amalia
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2017-01-04
- Volume
- 66
- Issue
- 4
- Pages
- 815-822
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2571158149
- Cited by
- 344
- References
- 41
- Citations by year
- 2026: 20 · 2025: 35 · 2024: 35 · 2023: 44 · 2022: 46 · 2021: 62 · 2020: 43 · 2019: 28 · 2018: 25 · 2017: 6
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- EU Horizon 2020 project EpoS (634413)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- adipose tissue insulin resistance, type 2 diabetes, impaired glucose tolerance, beta-cell function, free fatty acids, insulin resistance, obesity, glucose tolerance, Matsuda index
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Obesity, Glucose Clamp Technique, Case-Control Studies, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.